Melbourne, Australia – September 27, 2025 – Incannex Healthcare Limited (NASDAQ: IXHL) is on the cusp of a pivotal week, with its Q4 2025 earnings report scheduled for release on Monday, September 29, 2025, before market open. This highly anticipated announcement is expected to inject significant volatility into the stock, with analysts predicting a possible price swing of +/- 63.21% on the first trading day. For investors and options traders, the coming days represent a critical juncture, demanding careful consideration of both potential directional movements and volatility-driven strategies.
The biotech firm, known for its cannabinoid and psychedelic medicine research, has a history of dramatic price movements tied to clinical trial progress. The upcoming earnings call, slated for Friday, October 3, 2025, will offer further insights into the company’s financial health and pipeline advancements, setting the stage…
